Created at	Source	Raw Value	Validated value
March 17, 2022, 5 p.m.	oms	The proportion of participants with a titre of blood neutralising antibodies to the SARS-CoV-2 Delta variant of >1:100 in the immediate vaccination group[Two weeks after the 3rd dose of the Pfizer vaccine]	The proportion of participants with a titre of blood neutralising antibodies to the SARS-CoV-2 Delta variant of >1:100 in the immediate vaccination group[Two weeks after the 3rd dose of the Pfizer vaccine]